Nitric Oxide Protects Bacteria from Aminoglycosides by Blocking the Energy-Dependent Phases of Drug Uptake
Reads0
Chats0
TLDR
Findings provide evidence for a model in which repression of aerobic respiration by NO fluxes associated with host inflammatory responses can reduce drug uptake, thus promoting resistance to several members of the aminoglycoside family in phylogenetically diverse bacteria.Abstract:
Our investigations have identified a mechanism by which exogenous production of nitric oxide (NO) induces resistance of Gram-positive and -negative bacteria to aminoglycosides. An NO donor was found to protect Salmonella spp. against structurally diverse classes of aminoglycosides of the 4,6-disubstituted 2-deoxystreptamine group. Likewise, NO generated enzymatically by inducible NO synthase of gamma interferon-primed macrophages protected intracellular Salmonella against the cytotoxicity of gentamicin. NO levels that elicited protection against aminoglycosides repressed Salmonella respiratory activity. NO nitrosylated terminal quinol cytochrome oxidases, without exerting long-lasting inhibition of NADH dehydrogenases of the electron transport chain. The NO-mediated repression of respiratory activity blocked both energy-dependent phases I and II of aminoglycoside uptake but not the initial electrostatic interaction of the drug with the bacterial cell envelope. As seen in Salmonella, the NO-dependent inhibition of the electron transport chain also afforded aminoglycoside resistance to the clinically important pathogens Pseudomonas aeruginosa and Staphylococcus aureus. Together, these findings provide evidence for a model in which repression of aerobic respiration by NO fluxes associated with host inflammatory responses can reduce drug uptake, thus promoting resistance to several members of the aminoglycoside family in phylogenetically diverse bacteria.read more
Citations
More filters
Journal Article
Small Colony Variants: a Pathogenic Form of Bacteria that Facilitates Persistent and Recurrent Infections
TL;DR: This review covered the phenotypic, genetic and clinical picture associated with small colony variants, with an emphasis on staphylococci, for which the greatest amount of information is available.
Journal ArticleDOI
Aminoglycoside Antibiotics in the 21st Century
Bernd Becker,Mark E. Cooper +1 more
TL;DR: It is time to have a fresh look at this old class of aminoglycoside antibiotics to reinvigorate the struggle against multidrug-resistant pathogens.
Journal ArticleDOI
Nitric oxide: a key mediator of biofilm dispersal with applications in infectious diseases.
TL;DR: Overall the use of low levels of NO exploiting its signaling properties to induce dispersal represents an unprecedented and promising strategy for the control of biofilms in clinical and industrial contexts.
Journal ArticleDOI
Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
Robert P. Howlin,Katrina Cathie,Katrina Cathie,Luanne Hall-Stoodley,Luanne Hall-Stoodley,Victoria Cornelius,C Duignan,C Duignan,Raymond N. Allan,Bernadette O. Fernandez,Nicolas Barraud,Kenneth D. Bruce,Johanna M.C. Jefferies,Michael J. Kelso,Staffan Kjelleberg,Staffan Kjelleberg,Scott A. Rice,Scott A. Rice,Geraint B. Rogers,Geraint B. Rogers,Sandra Pink,Caroline A. Smith,Priya Sukhtankar,Priya Sukhtankar,Rami J. Salib,Julian Legg,Mary P. Carroll,Thomas Daniels,Martin Feelisch,Paul Stoodley,Stuart C. Clarke,Gary Connett,Saul N. Faust,Jeremy S. Webb +33 more
TL;DR: A benefit of using low-dose NO as adjunctive therapy to enhance the efficacy of antibiotics used to treat acute P. aeruginosa exacerbations in CF is suggested.
Journal ArticleDOI
Mannitol Enhances Antibiotic Sensitivity of Persister Bacteria in Pseudomonas aeruginosa Biofilms
TL;DR: The results suggest that in addition to improvements in lung function by facilitating mucus clearance in CF, mannitol also affects antibiotic sensitivity in biofilms and does so through an active, physiological response.
References
More filters
Journal ArticleDOI
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
TL;DR: A simple and highly efficient method to disrupt chromosomal genes in Escherichia coli in which PCR primers provide the homology to the targeted gene(s), which should be widely useful, especially in genome analysis of E. coli and other bacteria.
Journal ArticleDOI
Acetylornithinase of Escherichia coli: partial purification and some properties.
Henry J. Vogel,David M. Bonner +1 more
TL;DR: Compounds Used-N”l-Acetyl-n-ornithine was synthesized as previously described and L-Ornithine monohydrochloride was obtained from the Mann Research Laboratories.
Journal ArticleDOI
Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant.
TL;DR: Two cassettes with tetracycline-resistance (TcR) and kanamycin-res resistance (KmR) determinants have been developed for the construction of insertion and deletion mutants of cloned genes in Escherichia coli.
Journal ArticleDOI
Mammalian nitric oxide synthases.
TL;DR: This report summarizes some of the current information regarding NO synthase structure-function, reaction mechanism, control of catalysis, and protein interactions.